anx_III__cpt_2__cpt_2__point_9__text_1 — Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16… · Lexiara

anx_III__cpt_2__cpt_2__point_9__text_1

Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC Text with EEA relevance · European Union

If information on expectedness has been provided by the reporting investigator, this shall be taken into consideration by the sponsor.

← 9. · All articles · 2.3. Information for the reporting of SUSARs →

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.